LensGen is an ophthalmic medical device company developing a curvature changing fluid lens to address presbyopia and cataracts.

LensGen

LensGen, Inc. | 466 followers on LinkedIn. Restoring Youthful Vision | LensGen® is an ophthalmic medical device company that has developed a biomimetic, Curvature Changing Fluid-Optic Intraocular Lens designed for the treatment of cataracts and presbyopia.

When we reach an age of 40 we begin to lose the ability to focus at near objects. The medical term for this condition is called presbyopia.

President at Packer Research Associates, Inc.

Mark Packer

Chief Operating Officer at LensGen, Inc

Michael Landreville

Staff Acct./purchasing/ Admin.

Sissy Jao

Medical Affairs Consultant

Laura Fletcher

LensGen, Inc.

Viewport Meta

IPhone / Mobile Compatible

Google Font API

WordPress

Organization Schema

reCAPTCHA

Sitelinks Search Box

Yoast WordPress SEO Plugin

Yoast Plugins

Yoast SEO Premium

Chief Executive Officer

Ramgopal Rao

Senior Director of Engineering

Dan Brady

Director of QA/QC

Leah Summers

Director of Clinical and Regulatory Affairs

Patrick Casey

Manager of Quality Assurance

Vicki Ballon

Human Resources Assistant

Christine Nguyen

Principal Quality Engineer

Derek So

Finance and Administration

Jade Thurman

Clinical Research Associate

Misty Robe

James Mazzo

Clinical Research

Western US Medical Companies (Top 10K)

Medical Device Companies With Fewer Than 100 Employees (Top 10K)

Medical Companies With More Than 10 Employees (Top 10K)

Medical Device Companies With Less Than $50M in Revenue (Top 10K)

LensGen is an ophthalmic medical device company that has developed a biomimetic, curvature changing fluid-optic intraocular lens designed for the treatment of cataracts and presbyopia. It offers Juvene™ which is designed to fit inside the same location as the natural human lens and adjusts dioptric power on demand through curvature change by using the same tiny muscle contractions that occur within the eye.

Hoya Corporate Venture Capital Group

Venture Round - LensGen

HOYA Group

Series A - LensGen

Seed Round - LensGen

Grant - LensGen

Irvine

California

United States

North America

Future of IOLs: Modular, shape-changing, multifunctional

FDA grants IDE nod to LensGen’s presbyopia-correcting intraocular lens

LensGen closes $10 million in bridge financing

ArcScan Adds Ramgopal 'Ram' Rao to Board of Directors

LensGen updates on Juvene IOL, adds $15m to Series A

A fluid-optic intraocular lens designed to treat cataracts and presbyopia by mimicking the natural human lens and adjusting curvature to restore vision.

Turkey

Europe

India

Asia

HTML5

Google Fonts

Microsoft Outlook

Google Drive

jQuery

Google Doubleclick

Google Analytics

Adobe Flash

Office 365

Comodo PositiveSSL Certificates

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 14, 2024 10:37 AM	cb128db6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 10:37 AM	a5c44bf0
crunchbase trigger	general	Nov 14, 2024 10:37 AM	2e8bde54
crunchbase profile	general	Nov 15, 2024 2:35 AM	23d10182
li profile	general	Nov 14, 2024 10:37 AM	688cdd2e
translate crunchbase fundingrounds	general	Nov 15, 2024 3:27 AM	a9b4b4d1
peers	general	Nov 14, 2024 10:37 AM	60ae2572
news basic	general	Nov 14, 2024 10:37 AM	36824b37
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

LENS

COM:LENSGEN

LensGen